81
68
Growth Score 81 in past quarter
-8 pts
Heat Score 68 in past quarter
-15 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
577025
Onkolyze helps doctors personalise chemotherapy treatment. Using data already captured as part of the clinical workflow.
- Rory Wilding: CEOPast Role: Supabase, Head of Growth
About the Company
Onkolyze helps doctors personalise chemotherapy treatment. Using data already captured as part of the clinical workflow, Onkolyze allows doctors to simulate patient specific outcomes for different chemotherapy treatments. This is achieved by unique combination of computer vision, artificial intelligence, and computer simulations. Optimising cancer
treatment for individuals improves patient outcomes and saves the healthcare ecosystem money.